FEATURED SAMPLES
IPD Analytics publishes a semiannual Drug Pipeline Report, which identifies new brands, generics, and biosimilars across more than 120 disease classes. Our team of pharmacists, PhD scientists, and intellectual property attorneys are consistently scanning and analyzing the landscape to provide insight into trending the classes that are impacting drug spend.
From our recently published Drug Pipeline Report for 1H 2021, we share five key drug pipeline areas to watch in 2021, including one you may not have expected.
Top 5 Drug Pipeline Areas to Watch in Early 2021
